Skip to main content
Clinical Trials/PACTR202301766708922
PACTR202301766708922
Recruiting
Phase 4

Opioid-free anesthesia monitored by analgesia nociceptive index for cirrhotic patients undergoing hepatic focal lesion resection

national liver street0 sites50 target enrollmentDecember 3, 2022
ConditionsAnaesthesia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Anaesthesia
Sponsor
national liver street
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
national liver street

Eligibility Criteria

Inclusion Criteria

  • cirrhotic patients candidate for hepatic resection with Child classification (A)

Exclusion Criteria

  • 1\-patients suffered from Major intraoperative events (e.g. severe hemodynamic instability, massive blood loss, massive blood products transfusion).
  • 2\-Allergic patients to any of the study drugs.
  • 3\- Opioid addiction.
  • 4\-Body\-mass index higher than 40 kg/m².
  • 5\-unwilling to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials